August 22, 2017 - By Louis Casey
Among 2 analysts covering DX Group Plc (LON:DX), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. DX Group Plc had 15 analyst reports since September 10, 2015 according to SRatingsIntel. On Wednesday, June 8 the stock rating was maintained by Cantor Fitzgerald with “Hold”. Numis Securities maintained the stock with “Hold” rating in Monday, February 29 report. The stock of DX (Group) PLC (LON:DX) has “Hold” rating given on Tuesday, May 10 by Numis Securities. The stock of DX (Group) PLC (LON:DX) has “Hold” rating given on Wednesday, March 2 by Cantor Fitzgerald. Numis Securities maintained it with “Buy” rating and GBX 110 target in Monday, September 21 report. The firm earned “Hold” rating on Wednesday, September 21 by Numis Securities. The firm has “Hold” rating by Cantor Fitzgerald given on Monday, November 16. On Tuesday, October 20 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Cantor Fitzgerald maintained DX (Group) PLC (LON:DX) rating on Wednesday, September 21. Cantor Fitzgerald has “Hold” rating and GBX 23 target. The stock of DX (Group) PLC (LON:DX) has “Hold” rating given on Monday, February 29 by Cantor Fitzgerald. See DX (Group) PLC (LON:DX) latest ratings:
Albert D Mason Inc decreased Novartis Ag Adr (NVS) stake by 59.16% reported in 2016Q4 SEC filing. Albert D Mason Inc sold 21,319 shares as Novartis Ag Adr (NVS)’s stock rose 4.17%. The Albert D Mason Inc holds 14,719 shares with $1.07 million value, down from 36,038 last quarter. Novartis Ag Adr now has $217.60B valuation. The stock increased 0.30% or $0.25 during the last trading session, reaching $83.02. About 400 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since August 22, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.
About 401,834 shares traded or 67.54% up from the average. DX (Group) PLC (LON:DX) has 0.00% since August 22, 2016 and is . It has underperformed by 16.70% the S&P500.
Since June 1, 2017, it had 0 buys, and 1 sale for $53,082 activity. 7,693 shares valued at $53,082 were sold by IGDALOFF BARRY on Thursday, June 1.
DX plc is engaged in the provision of parcels, mail and logistics services in the United Kingdom and Ireland. The company has market cap of 17.30 million GBP. The Company’s divisions include parcels and freight, mail and packets, and logistics. It currently has negative earnings. The parcels and freight segment offers services, such as DX 1-Man, engaged in the delivery of irregular dimension and weight items; DX Courier, which provides next day parcel services, and DX 2-Man, which offers a business to consumer home delivery solution for heavier and bulkier items.
Investors sentiment decreased to 1.32 in Q4 2016. Its down 0.75, from 2.07 in 2016Q3. It is negative, as 13 investors sold DX (Group) PLC shares while 31 reduced holdings. 18 funds opened positions while 40 raised stakes. 20.10 million shares or 4.35% less from 21.01 million shares in 2016Q3 were reported. Connor Clark And Lunn Inv Mngmt holds 56,700 shares or 0% of its portfolio. The New York-based Tower Ltd Liability Corp (Trc) has invested 0% in DX (Group) PLC (LON:DX). Menta Lc accumulated 77,890 shares. Systematic Fin L P reported 0.02% stake. Citadel Advsrs Ltd Co invested in 0% or 66,316 shares. Manufacturers Life Ins The stated it has 0% of its portfolio in DX (Group) PLC (LON:DX). Millennium Mngmt Limited Liability Co reported 175,710 shares. Kcg Holdings holds 53,308 shares. Wellington Mngmt Grp Llp reported 17,407 shares stake. State Board Of Administration Of Florida Retirement Sys reported 0% of its portfolio in DX (Group) PLC (LON:DX). Tiaa Cref Invest Management Limited Company stated it has 191,744 shares or 0% of all its holdings. Blackrock, a New York-based fund reported 2,820 shares. Geode Management Llc reported 0% in DX (Group) PLC (LON:DX). Cambridge Investment Research Advsr reported 67,872 shares stake. Fmr Ltd Liability Com reported 0% of its portfolio in DX (Group) PLC (LON:DX).
Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Novartis Ag had 29 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Market Perform” rating by Leerink Swann on Wednesday, March 23. On Friday, June 16 the stock rating was maintained by J P Morgan Chase Co with “Neutral”. The stock has “Underperform” rating by Mainfirst on Wednesday, October 28. On Tuesday, January 3 the stock rating was downgraded by JP Morgan to “Neutral”. The rating was downgraded by Morgan Stanley on Tuesday, April 12 to “Underperform”. The firm has “Neutral” rating given on Friday, March 24 by JP Morgan. Cowen & Co downgraded it to “Market Perform” rating and $77 target in Wednesday, April 5 report. The rating was initiated by Chardan Capital Markets on Tuesday, September 20 with “Buy”. Chardan Capital Markets maintained the shares of NVS in report on Monday, October 10 with “Buy” rating. Leerink Swann maintained the shares of NVS in report on Thursday, June 22 with “Hold” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.